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Abstract
The major compounds in the dermis are hyaluronan and type I collagen, which decrease with aging, UV and various 
other factors.  The loss of hyaluronan and collagen with aging is associated with increased dehydration and wrinkling of the 
skin.  We aimed to investigate the inﬂuence of hyaluronan tetrasaccharide (HA4) on regulation of high molecular weight hy-
aluronan (HA) and collagen synthesis in normal human dermal ﬁbroblasts (NHDFs).  Expression of hyaluronan synthase 
(HAS) 1–3 and collagen (COL) 1A1 mRNA were evaluated by quantitative real-time PCR.  HAS1 mRNA expression was 
found to be increased in NHDFs treated with HA and HA4.  In addition, it was observed that NHDFs co-cultured with nor-
mal human epidermal keratinocytes (NHEKs) showed up-regulation of HAS1 mRNA expression, as compared with NHDFs 
single cell culture treated with HA4.  Treatment of NHDFs with HA4 ? derivatized vitamin C (VC-PMg) signiﬁcantly in-
creased COL1A1 mRNA expression.  In this study, we conﬁrmed that HA4 affected HAS1 and COL1A1 mRNA expression; 
thus, HA4 application may show various action in skin.
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1.?Introduction
Hyaluronan, which is composed of repeated β-1,4-gluc-
uronic acid-β-1,3-N-acetylglucosamine disaccharide units, is a 
non-sulfated glycosaminoglycan with a molecular weight of 
over 1,000 kDa.  Hyaluronan is abundant in the extracellular 
matrix (ECM) of the skin, and is involved in many biological 
processes such as tissue homeostasis, cell proliferation, cell 
migration, cell differentiation, angiogenesis, tumor biology 
and repair processes by interacting with various proteins1).  In 
addition, because of physical properties such as viscoelastici-
ty, hydrophilicity and extensibility, hyaluronan seems to play 
an important role as a space ﬁller, osmotic buffer, plasma pro-
tein sieve and lubricant2).  In the skin, hyaluronan synthases 
(HAS) are synthesized by dermal ﬁbroblasts and epidermal 
keratinocytes.  Synthesis of hyaluronan is accomplished by 
three HAS (HAS1, HAS2 and HAS3), which produce differ-
ent sizes of polysaccharide chains with average molecular 
weights of about 3?105 to 2?106 Da for HAS1 and HAS2, 
and about 2?105 to 3?105 Da for HAS33).
Collagen is a major component of ECM, and type I colla-
gen accounts for approximately 80? of the total collagen in 
adult human dermis4).  Type I collagen is a product of two 
genes, α1 (I) (COL1A1) and α2 (I) (COL1A2), which are co-
ordinately regulated5).  The major structural protein in the der-
mis is type I collagen, which comprises 90? of the dry weight 
of skin and diminishes with normal aging6)–8).  Collagen plays 
a role in cell adhesion, and is important for maintaining nor-
mal tissue architecture and function.
Stimulation of living tissue by hyaluronan appears to de-
pend on various factors, including hyaluronan chain length. 
For example, high molecular weight hyaluronan was demon-
strated to suppress angiogenesis9) and inﬂammation10), where-
as low molecular weight hyaluronan stimulated induction of 
angiogenesis11), inﬂammation12) and expression heat shock 
protein 7213).  In addition, injection of cross-linked hyaluronan 
stimulates collagen synthesis, partially restoring dermal ma-
trix components that are lost in photo-damaged skin14).  In this 
way, hyaluronan possesses numerous functions, but little is 
known about the effects of hyaluronan oligosaccharides on 
skin.
In this study, we aimed to investigating the inﬂuence of 
high molecular weight hyaluronan (HA) and hyaluronan tetra-
saccharide (HA4) on regulation of HASs and COL1A1 




HA4 (99.14?) (776.3 Da) was provided by Glycoscience 
Laboratories Inc. (Tokyo, Japan).  HA (?1,200 kDa) pro-
duced by a Streptococcus zooepidemicus was used.  All other 
chemicals and solvents were of analytical grade.  Abdominal 
skin origin normal human dermal ﬁbroblasts (NHDFs) were 
purchased from Kurabo (Osaka, Japan).  Abdominal skin ori-
gin normal human epidermal keratinocytes (NHEKs) were 
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purchased from Biopredic (Rennes, France).  HuMedia-KG2 
was purchased from Kurabo (Osaka, Japan).  Fetal bovine se-
rum (FBS) was purchased from Nichirei Bioscience (Tokyo, 
Japan), and Dulbecco?s modiﬁed Eagle?s medium (DMEM) 
was from Wako Pure Chemical Industries, Ltd. (Osaka, Ja-
pan).  Magnesium ascorbyl phosphate (VC-PMg) was ob-
tained from Nikko Chemicals (Tokyo, Japan).  RNAiso Plus, 
PrimeScript® RT reagent Kit and SYBR® Premix Ex TaqTM 
were purchased from TaKaRa Bio (Shiga, Japan).  Primers 
were purchased from Invitrogen (CA, U.S.A.).
2–2.?Cell culture
NHDFs were seeded into 100-mm dishes (1.0?105 cells 
per dish), and were cultured in DMEM supplemented with 10
? FBS.  NHEKs were seeded into 100-mm dishes (2.0?105 
cells per dish), and were cultured in HuMedia-KB2 supple-
mented with 10 μg/ml insulin, 0.1 ng/ml human epidermal 
growth factor, 0.5 μg/ml hydrocortisone, 50 μg/ml gentamicin, 
50 ng/ml amphotericin B, and 0.4? (v/v) bovine pituitary ex-
tract.  Cells were incubated in a humidiﬁed atmosphere of 5? 
CO2 at 37ºC, and culture medium was changed every day.  Af-
ter cells had become subconﬂuent, they were subcultured in 
60-mm dishes (0.3–0.5?105 cells per dish) in the same medi-
um.  After culture for 1 day, cells were treated at doses of 
0.1 μg/ml HA or HA4, followed by further culture.
2–3.?Keratinocyte-ﬁbroblast co-culture
NHDFs were plated into six-well plates at 0.2?105 cells 
per well.  At the same time, NHEKs were plated into BD Fal-
con Cell Culture Inserts at 0.2?105 cells per insert.  These in-
serts consist of a porous translucent low-protein binding poly-
ethylene terephthalate (PET) membrane with a pore size of 
0.4 mm and pore density of 1?108 pores per cm2.  After cul-
ture for 1 day, NHEKs were treated at doses of 0.1 μg/ml HA 
or HA4, followed by further culture.  
2–4.?MTT assay
NHEKs were seeded on 24-well culture plates and incubat-
ed for 1 day.  After treatment with HA and HA4 for 24 h, cells 
received 0.5 mg/ml MTT solution and were incubated for a 
further 3 h.  Medium was removed and the resulting formazan 
crystal was solubilized in 1 ml of 0.04 M hydrochloric acid/
isopropyl alcohol.  Optical density at 570 nm was determined 
using a microplate reader (SpectraMax M2e; Molecular De-
vices, Tokyo, Japan).
2–5.?RNA extraction and quantitative real-time PCR
Total RNA was isolated from cells following standard pro-
cedures using RNAiso Plus.  First-strand cDNA was synthe-
sized from 0.5 μg total RNA from cells sample using Prime-
Script® RT reagent Kit and thermal cycler (Veriti; Applied 
Biosystems, CA, USA).  The cDNA samples generated were 
diluted and used for real-time PCR analysis.  Brieﬂy, 2 μl of 
diluted cDNA was mixed with both forward and reverse prim-
ers (Table 1) and SYBR® Premix Ex TaqTM in 20 μl ﬁnal vol-
umes.  Ampliﬁcation was performed using the Real-Time 
PCR System (ABI PRISM® 7500; Applied Biosystems).  Am-
pliﬁed PCR products were quantiﬁed by measuring each gene 
and GAPDH mRNA calculated cycle thresholds (CT).  The 
amount of speciﬁc mRNA in samples was calculated from the 
standard curve and normalized with the GAPDH mRNA.  The 
results were expressed as an n-fold difference relative to nor-
mal controls (relative expression levels).
2–6.?Data analysis
Analysis was performed using Statistical Analysis SAS sta-
tistical software ver. 9.2 (SAS Institute, Cary, NC).  P-values 
were derived from Dunnett?s or Tukey?s post-hoc multiple 
comparison test.
3.?Results
3–1.?Cytotoxicity of HA and HA4 on NHDFs
In order to investigate the cytotoxicity of HA and HA4 on 
NHDFs, we treated NHDFs with HA and HA4.  After treat-
ment for 24 h, cell viability was examined by MTT assay.  HA 
and HA4 showed no cytotoxicity up to a dose of 0.1 μg/ml 
(Fig. 1).
3–2.?HAS mRNA expression in NHDFs and NHEKs by 
HA and HA4 treatment
mRNA expression levels of HAS, relative to glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH), were assessed 
by quantitative real-time PCR in NHDFs.  NHDFs were cul-
tured with DMEM (control), HA or HA4 for 24 h.  HA and 
HA4 was applied at doses of 0.1 μg/ml.  After 24 h of treat-
ment, quantitative real-time PCR was used to determine the 
levels of HAS1, HAS2 and HAS3 mRNA relative to the con-
trol gene.  Treatment of NHDFs with HA and HA4 signiﬁ-
cantly increased HAS1 mRNA expression, but HAS2 and 
Table 1.?Primers.
Primer Sequence
GAPDH Forward 5?-GAAGGTGAAGGTCGGAGT-3?Reverse 5?-GAAGATGGTGATGGGATTTC-3?
HAS1 Forward 5?-ACGTGCGGATCCTTAACCCT-3?Reverse 5?-AGGCCTAGAGGACCGCTGAT-3?
HAS2 Forward 5?-GTCATGGGCAGAGACAAATCAG-3?Reverse 5?-CGTTACGTGTTGCGAGCTTTC-3?
HAS3 Forward 5?-GGGCATTATCAAGGCCACCTA-3?Reverse 5?-CAGATTTGTTGATGGTAGCAATGG-3?
COL1A1 Forward 5?-CCGCCGCTTCACCTACAGC-3?Reverse 5?-TTTTGTATTCAATCACTGTCTTGCC-3?
Fig. 1.  Effects of HA and HA4 treatment on cell viability of 
NHDFs.  Cell viability was determined by MTT assay.  
NHDFs were treated for 24 h with 0.1 μg/ml HA and 
HA4.  Values are means?S.D. of three experiments.
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HAS3 mRNA expression were unchanged.  The increases 
were 1.7-fold by HA treatment, and 1.6-fold by HA4 treat-
ment (Fig. 2A).  Furthermore, after 48 h of treatment, HA and 
HA4 further increased HAS1 mRNA expression (Fig. 2B). 
Next, to determine whether HA and HA4 treatment affects the 
expression of HAS mRNA, cultured NHEKs were incubated 
with 0.1 μg/ml HA or HA4 for 24 h.  No signiﬁcant differenc-
es in HAS mRNA expression were detected between HA and 
HA4 treated samples and untreated controls (Fig. 3).
3–3.?Effects of HA and HA4 treatment HAS mRNA ex-
pression in co-culture
mRNA expression of HAS was assessed by quantitative 
real-time PCR in NHEK-NHDF co-culture.  Treatment of 
NHEKs with HA and HA4 increased HAS1 mRNA expres-
sion in NHDFs (6.6-fold increase with HA, and 5.0-fold in-
crease with HA4; Fig. 4).
3–4.?COL1A1 mRNA expression in NHDFs by HA and 
HA4 treatment
mRNA expression of COL1A1 was assessed by quantita-
tive real-time PCR in NHDFs.  Treatment of NHDFs with HA 
and HA4 were small increased (not signiﬁcant) COL1A1 
mRNA expression (Fig. 5A).  Furthermore, combinations of 
HA4 and VC-PMg were accompanied by additional increases 
in COL1A1 mRNA expression (Fig. 5B). 
4.?Discussion
In this study, we examined the effects of HA and HA4 on 
HAS and COL1A1 expression in an in vitro study.  The re-
sults showed that treatment of NHDFs with HA and HA4 in-
creased HAS1 and COL1A1 mRNA expression.
Although hyaluronan is a simple, unbranched polysaccha-
ride chain composed of repeating disaccharide units, it exerts 
Fig. 2.  Effects of HA and HA4 treatment for 24 and 48 h on 
HAS1, HAS2 and HAS3 mRNA expression in NHDFs.  
HAS1, HAS2 and HAS3 mRNA expression was deter-
mined by quantitative real-time PCR.  NHDFs were 
treated for 24 h (a) and 48 h (b) with 0.1 μg/ml HA and 
HA4.  Values were normalized against GAPDH house-
keeping gene levels and were compared with untreated 
controls.  Values are means ? S.D. of three experi-
ments.
 *p?0.05, **p?0.01, Tukey?s post-hoc multiple com-
parison test.
Fig. 3.  Effects of HA and HA4 treatment for 24 h on HAS1, 
HAS2 and HAS3 mRNA expression in NHEKs.  
HAS1, HAS2 and HAS3 mRNA expression was deter-
mined by quantitative real-time PCR.  NHEKs were 
treated for 24 h with 0.1 μg/ml HA and HA4.  Values 
were normalized against GAPDH housekeeping gene 
levels and were compared with untreated controls.  Val-
ues are means ? S.D. of three experiments.
Fig. 4.  Effects of HA and HA4 treatment for 24 h on HAS1, 
HAS2 and HAS3 mRNA expression in co-culture of 
NHDFs and NHEKs.  HAS1, HAS2 and HAS3 mRNA 
expression in NHDFs was determined by quantitative 
real-time PCR.  Normal was monolayer culture of 
NHDFs.  NHEKs were treated for 24 h with 0.1 μg/ml 
HA and HA4.  Values were normalized against GAP-
DH housekeeping gene levels and were compared with 
untreated controls.  Values are means ? S.D. of three 
experiments.
 *p ? 0.05, **p ? 0.01, Tukey?s post-hoc multiple 
comparison test.
Fig. 5.  Effects of HA and HA4 treatment for 24 h on COL1A1 
mRNA expression in NHDFs.  COL1A1 mRNA ex-
pression was determined by quantitative real-time PCR.  
(a) NHDFs were treated for 24 h with 0.1 μg/ml HA 
and HA4.  Values were compared with untreated con-
trols.  (b) NHDFs were treated with HA?VC-PMg and 
HA4?VC-PMg.  Values were compared with VC-PMg 
treatment control (positive control; PC).  Values were 
normalized against GAPDH housekeeping gene levels.  
Values are means ? S.D. of three experiments.
 *p ? 0.05, Dunnett?s post-hoc multiple comparison 
test.
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a broad spectrum of physiological functions depending on lo-
cation, concentration and chain length, by binding to hyaluro-
nan -binding proteins.  HAS1, HAS2 and HAS3 are the en-
zymes responsible for hyaluronan production.  While the sizes 
of the hyaluronan synthesized in vitro by HAS1 and HAS2 
were 3?105 to 2?106 Da, HAS3 expression leads to the syn-
thesis of a substantially smaller hyaluronan (2?105 to 3?105 
Da) 3).  In addition, these enzymes differ in catalytic activity 
(HAS3?HAS2?HAS1), as well as the sizes of their ﬁnal 
products15).  Depending on hyaluronan concentration changes 
in the cell environment, NHDFs regulate hyaluronan produc-
tion itself.  In our study, HAS1 mRNA expression was in-
creased in NHDFs treated with HA and HA4 (Figs. 2A, 2B). 
HAS mRNA expression in NHDFs treated with HA4 was 
similar to that after treatment with HA.  In contrast, HAS 
mRNA expression was unchanged in NHEKs treated with HA 
and HA4 (Fig. 3).  The major function of the epidermis is to 
provide a barrier between the external environment and the 
organism.  Thus, NHEKs showed no change in HAS mRNA 
expression, as hyaluronan production is not a major function. 
We have new experimental data that HA4 enhanced keratino-
cyte differentiation.  Thus, the function of HA4 in NHEKs is 
not hyaluronan synthesis, but rather, is related to keratinocyte 
differentiation.  HAS1 mRNA expression was increased in 
NHEK-NHDF co-cultures treated with HA and HA4 (Fig. 4). 
Treatment of ﬁbroblasts with growth factors (epidermal 
growth factor, platelet derived growth factor BB, and trans-
forming growth factor 1β) up-regulated HAS gene expression 
and increased HAS enzymes and hyaluronan production16). 
Therefore, HAS1 mRNA expression was increased in 
NHEKs-NHDFs, as compared with NHDFs, as a result of 
growth factor signaling.
Injectable dermal ﬁllers are becoming increasingly popular 
for improving skin contour defects related to aging (wrinkles 
and lines), depressed acne scars, and other traumatic or con-
genital conditions.  After cross-linked hyaluronan injections, 
collagen deposition around the ﬁller was found to be higher 
than in controls14).  In addition, VC-PMg was demonstrated to 
stimulate collagen synthesis17)–20).  In our study, treatment of 
NHDFs with HA4 tended result in increased COL1A1 mRNA 
expression (Fig. 5A).  Furthermore, COL1A1 mRNA expres-
sion was signiﬁcantly higher in NHDFs treated with HA4 ? 
VC-PMg when compared with single VC-PMg treatment 
(Fig. 5B).  This suggests that HA4 treatment may get involved 
in collagen synthesis.
In this study, HA4 was suggested to affect hyaluronan and 
collagen synthesis.  In aged skin, particularly photo-aged skin, 
HA content is signiﬁcantly lower.  On the other hand, by in-
jecting hyaluronan into the skin, symptoms of photo-aging, 
such as wrinkles, diminish.  Therefore, hyaluronan has been 
recognized as a compound that can suppress aging.  We previ-
ously reported that HA4 permeates through skin by passive 
diffusion.  In addition, we show that treatment of HA4 im-
proved skin functional recovery after UVA irradiation21).  In 
this study, HAS and COL1A1 mRNA expression of HA4 was 
similar to HA.  Hyaluronan can not penetrate into the skin be-
cause of high water solubility and a high molecular weight. 
For these reason, HA4 application may show various action in 
skin.
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